RE:Few points that support me not to sell THTX EUhhhhmmmmmmm, I concur!!
Many Red Flags in our once beloved company TH!!
1) OK, Soleus, Morgan Stanley...., but don't you think they are "hedged"???
2) and 4) is ridiculous! Insiders are holding 1% !!!!!!! of the shares. They have no vested intrest in this company and don't care to do another OO!!!!!(and yes, once i was a really big shareholder in terms of the other "big"???? ones.......).
3) Short intrest of no importance! Which investor would short a stock trading for weeks, months a merely few 1000 shares??? Many other and far better possibilities!
5) For over 20 years, no serious BParma was intrested, so now we should/could partner/sell to a Chinese company??? Because we are just so desperate??
6) Old stuff, even our most engaged BMember Mr SPCEO1 has no hope of high sales anymore.
Of course there is some HOPE they will have "something" in oncology and i am really HOPING they will succeed, but HOPE didn't bring me much money in the past.......! And like i said earlier on, there are other companies with "something" in oncology and they have CASH/PARTNERS/INSIDERS etc .
I sold the last TH shares for 3,30 CAD and they are now at 2,75 CAD!!! I still have some because i can't believe i am/was so wrong about this company, but for what i was invested earlier on and i believed would be a game changer i must admit i was wrong!
We will see what the future brings but in the meantime, most of my money is in a few other US oncology companies!
Good luck all of you ( and of course me also........) :-)
LouisW-(7/7/2022 2:34:07 AM)
Few points that support me not to sell THTX
1. Big shareholders barely sold the shares, furthermore, Morgan Stanley is accumulating shares significantly. Big shareholders shuch as Soleus and ALgh capital management bought a lot when the fast track designation was granted, meaning they are insertested in future of SORT1 techiqure.
2. In the past two years, no insider sold the shares. Instead, insiders bought a bunch of shares when the fast track designation was granted. I am wondering if to sell the shars is prohibited for insiders. If not, they are seemingly confident in the company's future.
3. The short interest achieves the historical low.
4. The members of senior management team barely quit. Typically, if they are not optimistic about company's future, they will quit instead of staying in the company thay are pessimistic with. This is consistent to the point 2...they are seemingly confident about company's future.
5. They have TH1902 which is potentially a game changer for treating cancer. Biotech companies which have a bunch of cash in China are eager to pay TH i order to obtain the right of SORT1 technique/TH1902. I actually went through all the literature about TH1902 and SORT1, i am confident that it will probably do its work.
6. And Egrifta, the revenue increases due to the more demand of EGRIFTA. EGRIFTA is potentially to treat NASH, cognitive impairment and neurodegernation. I just dont understand WHY they always have excuse to postpone the trial of NASH.
Despite all the points which may ideally drive the SP up, the SP somehow just nosedived anyway. I dont agree someone said that THTX doesnt care about investors. The insiders probably own more than you do (Dawn owns 273600 shares and Paul owns 111200 shares). However, the financial status and plan are my conserns, so far they dont have detailed plan to overcome the budget shortage in the future. Although the budget shortage is disturbing, cash will flow in if TH1902 works and actually i am confident to its performance. SO I personally dont see any signal telling me that i should sell THTX. But it is testing my nerves and patience honestly.